Disclosed are methods for treating cancer such as a myeloid malignancy such as multiple myeloma in a human using EZH2 inhibitors in human populations having a translocation MMSET or a decreased level of a functional UTX protein or both.
申请公布号
EP3119390(A2)
申请公布日期
2017.01.25
申请号
EP20150764406
申请日期
2015.03.21
申请人
GlaxoSmithKline Intellectual Property (No. 2) Limited;Northwestern University
